A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations
Pacing and Clinical Electrophysiology · 2023-06 · 46 (6) · 475-486
DOI: 10.1111/pace.14709 ↗At a glance
Beobachtungsstudie in Pacing and Clinical Electrophysiology, published online on 2023-05-02. Written by Kazuto Hayasaka and 17 co-authors. Institution: Heart Rhythm Center, National Hospital Organization Disaster Medical Center, Tokyo, Japan. Major MEDLINE topics: Atrial Fibrillation, Pulmonary Veins, Cryosurgery, Catheter Ablation. Cited 3 times so far (Crossref); 18 references.
Abstract (original language)
Backgrounds Catheter ablation for non‐paroxysmal atrial fibrillation (non‐PAF) remains challenging and more effective strategy has been required to reduce postoperative arrhythmia recurrences. This study aims to investigate the efficacy and safety of a novel extensive ablation strategy for non‐PAF, that is based on a combination of cryoballoon (CBA), radiofrequency (RFA), and Marshall‐vein ethanol ablations (EA‐VOM).
Methods
The study was a single‐center, retrospective observational study. We enrolled 171 consecutive patients who underwent de‐novo catheter ablation for non‐PAF under conscious sedation with a novel extensive ablation strategy that included CBA for pulmonary vein isolation (PVI) and left atrial roof ablation (LARA), RFA for mitral isthmus (MI) ablation, superior vena cava isolation, and other linear ablations and EA‐VOM. Recurrence of atrial arrhythmias over 1 year, procedure outcomes, and procedure‐related complications were investigated.
Results
A total of 139 (81.3%) patients remained in sinus rhythm during 1‐year follow‐up. Of the 139 patients, 51 patients (29.8%) received antiarrhythmic drugs. The mean procedure time was 204 ± 45 min. PVI and LARA ablation by CBA and MI block by RFA and EA‐VOM were completed in 171 (100%) and 166 (97.1%) patients, respectively. No serious procedure‐related complications were observed except for one case of delayed pericardial effusion.
Conclusion
Approximately 80% of the study patients were AF‐free during 1‐year follow‐up period after a single procedure based on the novel extensive ablation strategy combining CBA, RFA, and EA‐VOM. This strategy for non‐PAF may be preferred in terms of maintenance of sinus rhythm, safety even in high‐risk patients, and relatively short procedure time.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Heart Rhythm Center, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
- Department of Cardiology, Yokohama City Minato Red Cross Hospital, Kanagawa, Japan.
- Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
ORCID profiles: Takeshi Sasaki, Yasuhiro Shirai, Keita Watanabe, Kaoru Okishige
Cite
APA
Hayasaka, K., Sasaki, T., Shirai, Y., Shimosato, H., Tahara, T., Segami, S., Nagasawa, R., Akimoto, K., Yabe, K., Toya, C., Watanabe, K., Yamashita, S., Suzuki, M., Sugiyama, K., Yamauchi, Y., Okishige, K., Goya, M., & Sasano, T. (2023). A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations. Pacing and Clinical Electrophysiology, 46(6), 475-486. https://doi.org/10.1111/pace.14709
Vancouver
Hayasaka K, Sasaki T, Shirai Y, Shimosato H, Tahara T, Segami S, et al. A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations. Pacing and Clinical Electrophysiology. 2023;46(6):475-486. doi:10.1111/pace.14709
BibTeX
@article{Hayasaka2023,
author = {Hayasaka, Kazuto and Sasaki, Takeshi and Shirai, Yasuhiro and Shimosato, Hikaru and Tahara, Tomohiro and Segami, Shota and Nagasawa, Ryo and Akimoto, Ko and Yabe, Kento and Toya, Chisashi and Watanabe, Keita and Yamashita, Shu and Suzuki, Masahito and Sugiyama, Koji and Yamauchi, Yasuteru and Okishige, Kaoru and Goya, Masahiko and Sasano, Tetsuo},
title = {A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations},
journal = {Pacing and Clinical Electrophysiology},
year = {2023},
volume = {46},
number = {6},
pages = {475--486},
doi = {10.1111/pace.14709}
}
EUVIMED